Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8038266Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pathology
NIH Funding · FY2024
Linked Award Amount
$945.6K
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#16,149
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Chunhai Charlie Hao as a PI. Multi-PI records show the full award amount for context.
- 1R41AG090241-01R41Development of Small-Molecule Degraders of APP as the first-in-class drugs for Alzheimer's therapy$499.9Kaward amount
- 5R01NS126358-03R01Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.$445.7Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Chunhai Charlie Hao as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDegrome Therapeutics, Inc.
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Chunhai Charlie Hao.